Turnstone Biologics | 8-K: Current report
Turnstone Biologics | 8-K: Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics | 10-Q: Q2 2024 Earnings Report
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Rajangam Kanya
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Gould Robert J
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Gupta Rishi
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Jerel Davis
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Waddill William D.
Turnstone Biologics | 8-K: Current report
Turnstone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy J. Langer(4.3%)
Turnstone Biologics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Turnstone Biologics | 10-Q: Q1 2024 Earnings Report
Turnstone Biologics | 8-K: Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(5.994%),Abigail P. Johnson(5.994%)
Turnstone Biologics | ARS: Annual Report to Security Holders
Turnstone Biologics | DEFA14A: Others
Turnstone Biologics | DEF 14A: Definitive information statements
Turnstone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Waddill William D.
Turnstone Biologics | 3: Initial statement of beneficial ownership of securities-Director Waddill William D.
Turnstone Biologics | 8-K: Current report
No Data
No Data